Phathom Pharmaceuticals, Inc.
PHAT
In Oncology and Gastrointestinal Biotech as a Early Follower.
Jodie monitors PHAT’s market activity, durable peer group membership, and filing-linked connections.
SEC company filingsCIK 0001783183
Exposure map
Filing peers
No filing peers are available for this name yet.
Live connections
PHAT is currently in Oncology and Gastrointestinal Biotech. No verified filing-linked names are available yet.
Theme membership history
No durable theme membership has been observed for this name yet.